Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom
Abstract
Authors
S. Chang L. Sawyer F. Dejonckheere L.W. van Suijlekom-Smit J. Anink A. Diamantopoulos
S. Chang L. Sawyer F. Dejonckheere L.W. van Suijlekom-Smit J. Anink A. Diamantopoulos
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now